For research use only. We do not sell to patients.
CB 300919
CAS No. : 289715-28-2
Biological Activity：CB 300919 is a quinazoline-based antitumour agent with high activity in the CH1 human ovarian tumour xenograft. CB 300919 has a continuous exposure (96 h) growth inhibition IC50 value of 2 nM in human CH1 ovarian tumor xenograft.
Research Area：Cancer
Targets：NAMPT
Related Screening Libraries:Covalent Screening Library Plus;Bioactive Compound Library Plus;Metabolism/Protease Compound Library;Anti-Cancer Compound Library;Covalent Screening Library;
Related Small Molecules:Teglarinad chloride;GNE-617;NAMPT inhibitor-linker 2;NAMPT degrader-1;Nampt-IN-8;Nampt-IN-3;Nampt-IN-10 TFA;Nampt-IN-7;SBI-797812;LB-60-OF61;Nampt-IN-5;CB30865;GPP78;NAT;Nampt-IN-1;LB-60-OF61 hydrochloride;STF-118804;OT-82;CHS-828;Nampt-IN-9;(E)-Daporinad;GNE-618
Trending products：Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides
About Us:
- MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use；
- Structurally and synthetically diverse biologically active compounds；
- roduct quality is the key to our success and we take pride in offering only the highest-grade products.；
- We provide HNMR, LC-MS, HPLC, stability testing and activity assays of our products to clients.；
- Product identity, quality, purity and activity are assured by our robust quality control programs and procedures.；
- Customized order volume ranging from milligrams to kilograms scale；
Structurally and synthetically diverse biologically active compounds；
We provide customer-oriented services. To explore more, please contact us at [email protected]. Our team will gladly assist you.
